Prescription drugs

Prescription drugs

The push to prescribe: women & Canadian drug policy

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Author: 
Anne Rochon Ford, Ed.
Diane Saibil, Ed.
Publisher: 
Women’s Press (Now owned by Canadian Scolar's Press)
Publication Date: 
July 2009
Publication Place: 
Toronto, ON

Delves into the world of prescription drugs in Canada, and considers the impact on the health of women. From the inadequate testing of many drugs on women in clinical trials, to the sometimes questionable portrayal of women in illegal prescription drug advertising, Canadian drug policy has not always paid attention to how women and men are affected differently. 297pp, Paperback

Available From: 
Order Information: 
Contact the publishing company to order.
ISBN/ISSN: 
ISBN -13 978-0-88961-478-9
Notes: 
Includes bibliographical references and index.

Do pregnant women benefit from taking antidepressants?

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Paper
Online
Author: 
Jane Shulman
Edition: 
Vol.12 No.1
Publisher: 
Canadian Women's Health Network
Publication Date: 
Fall/Winter 2009/2010
Publication Place: 
Winnipeg, MB

This article investigates whether or not there is evidence that antidepressant prescription drugs benefit pregnant women and if that benefit outweighs the potential risks.  Author Jane Shulman refers to Dr. Barbara Mintzes' expertise on the growing trend for doctors to encourage women to continue taking anti-depressants when they get pregnant.

Order Information: 
Contact their office to order a copy. Also available online.
ISBN/ISSN: 
ISSN 14800039

FDA hearing on flibanserin

Text Size: Normal / Medium / Large
Resource Language: 
English
Author: 
New View Campaign
Publisher: 
New View Campaign wesite
Publication Date: 
2010

Read the New View Campaign’s comments on US FDA hearings for approval of Flibanserin:

“On June 18, 2010, the FDA Reproductive Health Advisory Committee convenes for the second time to consider a drug for "female sexual dysfunction" (the first drug, Intrinsa, failed in 2004). The New View Campaign opposes the approval of flibanserin, and is preparing factsheets and petitions, has spoken to endless media, and will be participating in the hearing as part of the section on public speakers. In combination with the materials we prepared in 2004 for the Intrinsa hearing, these resources offer a rich analysis of the medicalization of sexuality.”

Available From: 
Order Information: 
Available online.

Generic drug pricing and access in Canada: what are the implications?

Text Size: Normal / Medium / Large
Resource Language: 
English
Author: 
Dr. Chaim Bell
Dr. David Griller
Joshua Lawson
Dusan Lovren
Publisher: 
Health Council of Canada
Publication Date: 
June 2010
Publication Place: 
Toronto, ON

Prescription drugs account for an increasing proportion of Canada’s growing health care system with rising costs that governments in this country are seeking ways to restrain.  The greater use of generic drugs, for which Canadians pay some of the highest prices in the world, accounts for a significant portion of these rising costs.  The Health Council of Canada commissioned this independent discussion paper to provide Canadians with some further insight into the generic drug sector and potential options to reduce generic drug prices.

Available From: 
Order Information: 
Contact their office to order a copy. Also available online.
ISBN/ISSN: 
ISBN 9781897463727
Notes: 
Health Council of Canada Suite 900, 90 Eglinton Avenue East Toronto, ON M4P 2Y3 Telephone: 416.481.7397 Toll Free: 1-866-998-1019 Facsimile: 416.481.1381 E-mail: information@healthcouncilcanada.ca

Submission from WHP to Health Canada in response to Blueprint for Renewal: Transforming Canada's Approach to Regulating Health Products and Food

Text Size: Normal / Medium / Large
Resource Language: 
English
Translated Title: 
Soumission d'APSF à Santé Canada en réponse au Plan de renouveau : transformer l'approche de la réglementation des produits de santé et des aliments au Canada
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Online
Author: 
Women and Health Protection
Publisher: 
Women and Health Protection
Publication Date: 
2006
Publication Place: 
Toronto, Ontario

Critique of Health Canada's “Blueprint for Renewal: Transforming Canada 's Approach to Regulating Health Products and Food.” Discusses direct-to-consumer advertising and the harms to women.

 

Available From: 

Remembering Ruth Cooperstock: women and pharmaceuticals 20 years later

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Centres of Excellence for Womens Health (CEWH)
Women and Health Protection (WHP)
Media Type: 
Paper
Online
Publisher: 
Women and Health Protection
Publication Date: 
2006
Publication Place: 
Toronto, ON

Presents the proceedings of a symposium that examined women and the pharmaceuticals industry. Includes presentations of the three panellists and a brief summary of each of the workshops.

Available From: 
ISBN/ISSN: 
ISBN 0973870141
WHP PHAR.R46 2005

Don't swallow everything you hear about women's health

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Centres of Excellence for Womens Health (CEWH)
Media Type: 
Paper
Online
Author: 
Kathleen O'Grady
Publisher: 
Canadian Women's Health Network
Publication Date: 
2006
Publication Place: 
Winnipeg, MB

Discusses women and medications.

Patient and physician attitudes and behaviors association with DTC promotion of prescription drugs: summary of FDA survey resear

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
Kathryn J Aikin
John L Swasy
Amie C Braman
Publisher: 
Food and Drug Administration, Center for Drug Evaluation and Research
Publication Date: 
2004
Publication Place: 
Rockville, MD

Explores patient and physician perspectives on DTC advertising as it relates to the healthcare experience. Indicates that DTC advertising has important positive and negative effects.

Available From: 
Notes: 
Includes bibliographical references.

Emergency contraception in Canada: increasing access and improving reproductive health

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Centres of Excellence for Womens Health (CEWH)
Media Type: 
Online
Author: 
Canadian Women's Health Network
Publisher: 
Canadian Women's Health Network
Publication Date: 
2005
Publication Place: 
Winnipeg, MB

Agrees with the proposal to change emergency contraceptive pills (ECPs) from a prescription drug to a non-prescription product. Argues that it should be available without pharmacist assistance or intervention.

Is it safe for my baby?

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Author: 
Diana Ballon
Publisher: 
Centre for Addiction and Mental Health
Publication Date: 
2003
Publication Place: 
Toronto, ON

Provides information about the relative risk and safety of prescription, over-the-counter and illegal drugs, along with alcohol, tobacco and other substances to the fetus during pregnancy and the baby during breastfeeding.

ISBN/ISSN: 
ISBN 0888684460
PREG.B35 2003
Notes: 
Review, Network Winter/Spring 2005: This booklet is for women who are planning a pregnancy, who are pregnant or breastfeeding. It gives information about the relative risks and safety to the fetus of prescription, over-the-counter and illegal drugs, along with alcohol, tobacco and other substances when the mother is pregnant, and to the baby, when breastfeeding. While the information in the booklet is a good starting point to address the questions of safety, it is also a great way for a woman to prepare herself for more in-depth talks with her doctor, midwife or pharmacist.
Syndicate content